Category Archives: ARV-based Intervention

WHO recommends PrEP for MSM: Time for the UK to take note and act?

In a surprising move, the World Health Organisation has come out in support of Pre-Exposure Prophylaxis (PrEP), recommending Men who have Sex with Men (MSM) to consider its use for HIV prevention alongside the use of condoms. It will be a huge challenge for countries

Is a Pill Enough to Fight HIV?

The New York Times started a debate on Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection by asking five prominent researchers and HIV advocates to discuss whether promoting the use of antiviral drugs was a good public health strategy, or if it will encourage more

The PARTNER study, a licence to bareback?

Absence of evidence is not evidence of absence. Does the PARTNER study signal the death of condoms or should we curb our enthusiasm, and carry on pretending we use them? The preliminary results of the PARTNER study were one of the most talked about data

No Thumbnail

What’s next for PrEP in the UK?

A reflexion on a piece written for and published by OpenDemocracy in November 2010, shortly after the public release of the iPrEX trial. Three years later many of the questions raised then are still very much relevant. Of course we now know much more about

No Thumbnail

A bleak future for PrEP in the UK

Limited community awareness, late and superficial institutional support, and cost-effectiveness issues paint a bleak future for Pre-Exposure Prophylaxis in the UK. On the opening day of the TasP PrEP Evidence Summit organised by IAPAC, Lord Fowler expressed his bemusement at the US attitude towards clean

Switch to our mobile site